| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.002 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |